Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DM1”

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06846437
What this trial is testing

JSKN003 Versus Trastuzumab Emtansine (T-DM1) for HER2-Positive, Advanced Breast Cancer

Who this might be right for
Unrespectable Locally Advanced and or Metastatic HER2 Positive Breast Cancer Participants
Shanghai JMT-Bio Inc. 228
Testing effectiveness (Phase 2)Study completedNCT02236000
What this trial is testing

A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 49
Testing effectiveness (Phase 2)Looking for participantsNCT05673928
What this trial is testing

A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)

Who this might be right for
Metastatic Solid TumorBrain Metastases
M.D. Anderson Cancer Center 30
Large-scale testing (Phase 3)Active Not RecruitingNCT06265428
What this trial is testing

Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
DualityBio Inc. 228
Testing effectiveness (Phase 2)Active Not RecruitingNCT04733118
What this trial is testing

Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer

Who this might be right for
Early Breast Cancer
MedSIR 393
Not applicableStudy completedNCT03829306
What this trial is testing

Unraveling KAdcyla Resistance In Human Epidermal Growth Factor Receptor 2(HER2) Positive Advanced Breast Cancer (KATIA)

Who this might be right for
Advanced Breast Cancer
Spanish Breast Cancer Research Group 32
Large-scale testing (Phase 3)Looking for participantsNCT06830889
What this trial is testing

BL-M07D1 Versus T-DM1 in the Adjuvant Treatment of HER2-positive Breast Cancer With Residual Invasive Cancer After Neoadjuvant Therapy

Who this might be right for
HER2-positive Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 1,450
Not applicableEnrolling By InvitationNCT06101940
What this trial is testing

Chinese Multicenter Clinical Outcome Cohort Study of Myotonic Dystrophy Type 1 (C-DMCOS-DM1)

Who this might be right for
Myotonic Dystrophy 1
Huashan Hospital 1,000
Not applicableStudy completedNCT03424460
What this trial is testing

Venous Thromboembolism in Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy 1
Assistance Publique - Hôpitaux de Paris 130
Testing effectiveness (Phase 2)Ended earlyNCT01702558
What this trial is testing

A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC)

Who this might be right for
Breast CancerGastric Cancer
Hoffmann-La Roche 182
Testing effectiveness (Phase 2)Looking for participantsNCT06667453
What this trial is testing

A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy 1
PepGen Inc 24
Testing effectiveness (Phase 2)Study completedNCT00233519
What this trial is testing

Effects of SomatoKine (Iplex)Recombinant Human Insulin-like Growth Factor-1/Recombinant Human Insulin-like Growth Factor-binding Protein-3 (rhIGF-I/rhIGFBP-3) in Myotonic Dystrophy Type 1 (DM1)

Who this might be right for
Myotonic Dystrophy
University of Rochester 17
Not applicableStudy completedNCT04209374
What this trial is testing

Retrospective Observational Cohort Study of SYMBOL CUP DM 1

Who this might be right for
Primary Total Hip Arthroplasty
Dedienne Sante S.A.S. 59
Not applicableStudy completedNCT04018820
What this trial is testing

Effects of a 12-week Strength Training Program in Men With Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy 1
Élise Duchesne 11
Not applicableEnrolling By InvitationNCT06979024
What this trial is testing

A Registered Observational Cohort Study of Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy Type 1 (DM1)
First Affiliated Hospital of Fujian Medical University 300
Testing effectiveness (Phase 2)Study completedNCT02858908
What this trial is testing

Study of Tideglusib in Adolescent and Adult Patients With Myotonic Dystrophy

Who this might be right for
Myotonic Dystrophy 1
AMO Pharma Limited 16
Not applicableStudy completedNCT05662150
What this trial is testing

Low-frequency Repetitive Nerve Stimulation in Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy 1
Vrije Universiteit Brussel 9
Not applicableUnknownNCT03554590
What this trial is testing

DM1, Effects of Carbo-Counting on Glycemic Control

Who this might be right for
Type 1 Diabetes Mellitus
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 50
Early research (Phase 1)Ended earlyNCT03429101
What this trial is testing

Poziotinib in Combination With T-DM1 in HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Spectrum Pharmaceuticals, Inc 6
Not applicableStudy completedNCT02308657
What this trial is testing

Multicenter Observational Study of Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy Type 1
University of Rochester 120
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation